177 related articles for article (PubMed ID: 11159174)
1. Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation.
Miyasaka T; Morishima-Kawashima M; Ravid R; Heutink P; van Swieten JC; Nagashima K; Ihara Y
Am J Pathol; 2001 Feb; 158(2):373-9. PubMed ID: 11159174
[TBL] [Abstract][Full Text] [Related]
2. [Molecular analysis of tau deposited in the FTDP-17 brain].
Morishima-Kawashima M
Rinsho Shinkeigaku; 2001 Dec; 41(12):1107-10. PubMed ID: 12235810
[TBL] [Abstract][Full Text] [Related]
3. Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation.
Miyasaka T; Morishima-Kawashima M; Ravid R; Kamphorst W; Nagashima K; Ihara Y
J Neuropathol Exp Neurol; 2001 Sep; 60(9):872-84. PubMed ID: 11556544
[TBL] [Abstract][Full Text] [Related]
4. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
[TBL] [Abstract][Full Text] [Related]
5. Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau.
DeTure M; Ko LW; Easson C; Yen SH
Am J Pathol; 2002 Nov; 161(5):1711-22. PubMed ID: 12414518
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic variation in hereditary frontotemporal dementia with tau mutations.
van Swieten JC; Stevens M; Rosso SM; Rizzu P; Joosse M; de Koning I; Kamphorst W; Ravid R; Spillantini MG; Niermeijer ; Heutink P
Ann Neurol; 1999 Oct; 46(4):617-26. PubMed ID: 10514099
[TBL] [Abstract][Full Text] [Related]
7. The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo.
van Swieten JC; Bronner IF; Azmani A; Severijnen LA; Kamphorst W; Ravid R; Rizzu P; Willemsen R; Heutink P
J Neuropathol Exp Neurol; 2007 Jan; 66(1):17-25. PubMed ID: 17204933
[TBL] [Abstract][Full Text] [Related]
8. Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau.
Yotsumoto K; Saito T; Asada A; Oikawa T; Kimura T; Uchida C; Ishiguro K; Uchida T; Hasegawa M; Hisanaga SI
J Biol Chem; 2009 Jun; 284(25):16840-16847. PubMed ID: 19401603
[TBL] [Abstract][Full Text] [Related]
9. Expression of an altered form of tau in Sf9 insect cells results in the assembly of polymers resembling Alzheimer's paired helical filaments.
Gómez-Ramos A; Abad X; López Fanarraga M; Bhat R; Zabala JC; Avila J
Brain Res; 2004 May; 1007(1-2):57-64. PubMed ID: 15064135
[TBL] [Abstract][Full Text] [Related]
10. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
[TBL] [Abstract][Full Text] [Related]
11. Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model.
Krishnamurthy PK; Johnson GV
J Biol Chem; 2004 Feb; 279(9):7893-900. PubMed ID: 14660557
[TBL] [Abstract][Full Text] [Related]
12. Tau is a candidate gene for chromosome 17 frontotemporal dementia.
Poorkaj P; Bird TD; Wijsman E; Nemens E; Garruto RM; Anderson L; Andreadis A; Wiederholt WC; Raskind M; Schellenberg GD
Ann Neurol; 1998 Jun; 43(6):815-25. PubMed ID: 9629852
[TBL] [Abstract][Full Text] [Related]
13. Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients.
Rizzu P; Joosse M; Ravid R; Hoogeveen A; Kamphorst W; van Swieten JC; Willemsen R; Heutink P
Hum Mol Genet; 2000 Dec; 9(20):3075-82. PubMed ID: 11115852
[TBL] [Abstract][Full Text] [Related]
14. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
[TBL] [Abstract][Full Text] [Related]
15. Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: a novel action of R406W mutation.
Sahara N; Tomiyama T; Mori H
J Neurosci Res; 2000 May; 60(3):380-7. PubMed ID: 10797541
[TBL] [Abstract][Full Text] [Related]
16. The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules.
Pérez M; Lim F; Arrasate M; Avila J
J Neurochem; 2000 Jun; 74(6):2583-9. PubMed ID: 10820221
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39.
Sakaue F; Saito T; Sato Y; Asada A; Ishiguro K; Hasegawa M; Hisanaga S
J Biol Chem; 2005 Sep; 280(36):31522-9. PubMed ID: 15994305
[TBL] [Abstract][Full Text] [Related]
18. The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy.
Ostojic J; Elfgren C; Passant U; Nilsson K; Gustafson L; Lannfelt L; Froelich Fabre S
Dement Geriatr Cogn Disord; 2004; 17(4):298-301. PubMed ID: 15178940
[TBL] [Abstract][Full Text] [Related]
19. Subcortical neurofibrillary tangles and argyrophilic grains in a case of familial frontotemporal dementia with parkinsonism.
Kobayashi K; Sudo S; Matsubara R; Nakano H; Koshino Y
Parkinsonism Relat Disord; 2008 Aug; 14(6):513-6. PubMed ID: 18346925
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
